GlassScriptPhysician profile
Jonathan P Yrad
NPI 1053330647
$6,332.54
in general payments reported to CMS, 2019-2025
31 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $185 · 2021: $1,014 · 2022: $608 · 2023: $734 · 2024: $2,914 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,399 · Travel and Lodging: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,398.50 |
| Travel and Lodging | $1,471.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,770.04 | 2023-2024 | |
| Intuitive Surgical, INC. | $924.80 | 2024 | |
| Kerecis Limited | $559.07 | 2020-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Allergan, INC. | $514.28 | 2019-2022 | |
| Integra Lifesciences Corporation | $419.02 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $361.83 | 2019-2022 | |
| Smith+Nephew, INC. | $331.03 | 2019-2022 | |
| Abbvie INC. | $297.32 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps, Dalvance |
| Hydrofera LLC | $122.91 | 2021-2023 | Hydrofera Blue |
| Innovation Technologies INC | $107.01 | 2021 | |
| Ethicon US, LLC | $105.52 | 2019 | |
| Lifenet Health | $90.36 | 2023-2024 | Theragenesis Wound Matrix |
| Organogenesis INC. | $84.50 | 2021-2025 | Puraply, Cygnus Dual |
| Reprise Biomedical, INC. | $73.75 | 2021-2024 | Miro3d |
| Becton, Dickinson and Company | $62.03 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $56.30 | 2022-2023 | |
| Innocoll Pharmaceuticals Limited | $52.34 | 2021 | |
| Acera Surgical, INC. | $40.14 | 2022 | |
| Bsn Medical INC | $38.08 | 2024 | |
| Tela Bio, INC. | $37.47 | 2021-2022 | |
| Baxter Healthcare | $37.04 | 2025 | Perclot |
| Next Science LLC | $36.22 | 2019-2021 | |
| Polarityte, INC. | $36.03 | 2020 | |
| Misonix INC | $30.79 | 2020 | |
| Conmed Corporation | $26.20 | 2025 | Airseal |
| Senseonics, Incorporated | $26.00 | 2020 | |
| Solventum Corporation | $24.82 | 2025 | Prevena, V.A.C. Granufoam, V.A.C.Ulta |
| W. L. Gore & Associates, INC. | $18.70 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $17.46 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.44 | 2023 | Gattex |
| Pacira Pharmaceuticals Incorporated | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Yrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.